SEVENTH AMENDMENT TO LEASELease • March 30th, 2010 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances)
THIS SEVENTH AMENDMENT TO LEASE (“Amendment”) made as of the 17th day of November, 2008, by and between 111 BARCLAY ASSOCIATES (“Landlord”), sole beneficiary under CHICAGO TITLE LAND TRUST COMPANY, as successor trustee to LASALLE BANK NATIONAL ASSOCIATION, as successor trustee (“Trustee”) to AMERICAN NATIONAL BANK AND TRUST COMPANY OF CHICAGO, as Trustee under Trust Agreement (“Trust”) dated January 1, 1991 and known as Trust No. 113370-03 (“Landlord”) and BIOSANTE PHARMACEUTICALS, INC. (“Tenant”).
EIGHTH AMENDMENT TO LEASELease • March 30th, 2010 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances)
THIS EIGHTH AMENDMENT TO LEASE (“Amendment”) made as of the 8th day of September, 2009, by and between 111 BARCLAY ASSOCIATES (“Landlord”), sole beneficiary under CHICAGO TITLE LAND TRUST COMPANY, as successor trustee to LASALLE BANK NATIONAL ASSOCIATION, as successor trustee (“Trustee”) to AMERICAN NATIONAL BANK AND TRUST COMPANY OF CHICAGO, as Trustee under Trust Agreement (“Trust”) dated January 1, 1991 and known as Trust No. 113370-03 (“Landlord”) and BIOSANTE PHARMACEUTICALS, INC. (“Tenant”).
AMENDMENT NO. 1 TO COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • March 30th, 2010 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
This Amendment No. 1 to the Common Stock Purchase Agreement, dated as of March 24, 2010 (this “Amendment”), to the Common Stock Purchase Agreement dated as of December 15, 2008 (the “Purchase Agreement”) is entered into by and between BioSante Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), and Kingsbridge Capital Limited, an entity organized and existing under the laws of the British Virgin Islands (the “Investor”).
